Olympus (OTCMKTS:OCPNY) Shares Pass Above 50 Day Moving Average – Should You Sell?

Olympus Co. (OTCMKTS:OCPNY – Get Free Report)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $18.00 and traded as high as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares traded.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised Olympus to a “buy” rating in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy”.

Get Olympus alerts:

Check Out Our Latest Analysis on Olympus

Olympus Stock Down 1.4%

The company has a current ratio of 1.99, a quick ratio of 1.48 and a debt-to-equity ratio of 0.59. The stock has a 50 day simple moving average of $18.00 and a 200 day simple moving average of $18.00. The firm has a market capitalization of $23.15 billion, a PE ratio of 21.95, a PEG ratio of 1.07 and a beta of 0.70.

Olympus Company Profile

(Get Free Report)

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.

See Also

• Five stocks we like better than Olympus
• 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
• Snowflake and the Snowballing Impact of its AI Flywheel
• AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
• These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.